Two cases of acute lead poisoning due to occupational exposure to lead

Clinical Toxicology

Volumn 46, Issue 4, 2008, Pages 332-335

  Ogawa, Masanori ^a   Nakajima, Yoshiaki ^a   Kubota, Ryuichi ^a   Endo, Yoko ^a  

^a TOKYO ROSAI HOSPITAL   (Japan)

Author keywords

CaEDTA; Lead poisoning; Occupational exposure

Indexed keywords

EDETATE CALCIUM; LEAD;

ADULT; ANEMIA; ARTHRALGIA; ARTICLE; CHELATION; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MALE; OCCUPATIONAL HAZARD; PAINTING;

ADULT; CHELATING AGENTS; EDETIC ACID; ERYTHROCYTES; HUMANS; LEAD POISONING; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PROTECTIVE DEVICES; TREATMENT OUTCOME;

EID: 41149120585     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701816448     Document Type: Article

References (16)

1. American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the TLVs and BEIs with other worldwide occupational exposure values [CD-ROM]. Cincinnati: ACGIH, 2006.
2. International Program on Chemical Safety (IPCS). Environmental Health Criteria 165. Geneva: WHO, 1995.
3. Sakai T. Biomarkers of lead exposure. Ind Health 2000; 38:127-142.
4. Araki S, Sato H, Yokoyama K, Murata K. Subclinical neurophysiological effects of lead: A review on peripheral, central and autonomic nervous system effects in lead workers. Am J Ind Med 2000; 37:193-204.
5. Manton WI, Cook JD. High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid. Br J Ind Med 1984; 41:313-319.
6. Ikeya Y, Sakai T, Takeuchi Y, Araki T, Ushio K. Plasma lead concentrations as a direct indicator of current exposure to lead. Jap J Traumatol and Occup Med 1987; 35:834-838.
7. Sakai T, Ushio K, Ikeya Y. Mobilized plasma lead as an index of lead body burden and its relation to the heme-related indices. Ind Health 1998; 36:240-246.
8. Aono H, Araki S. The effects of CaEDTA injection on lead, zinc, copper and ALAD in erythrocyte, plasma and urine in lead-exposed workers: a 24-h observation. Int Arch Occup Environ Health 1984; 55:13-18.
9. Araki S, Aono H, Murata K. Mobilisation of heavy metals into the urine by CaEDTA: Relation to erythrocyte and plasma concentrations and exposure indicators. Br J Ind Med 1986; 43:636-641.
10. Barbosa F, Tanus-Santos JE, Gerlach RF, Parsons PJ. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005; 113:1669-1674.
11. Ishihara N, Shiojima S, Hasegawa K. Lead and zinic concentrations in plasma, erythrocytes, and urine in relation to ALA-D activity after intravenous infusion of Ca-EDTA. Br J Ind Med 1984; 41:235-240.
12. Ford M, Delaney KA, Ling L, Erickson T. Clinical Toxicology. St. Louis, MO: W. B. Saunders Company, 2001.
13. Olson KR. Poisoning & Drug Overdose, 2nd ed. Columbus, OH: McGraw-Hill Companies, 1994.
14. Catton MJ, Harrison MJG, Fullerton MP, Kazanzis G. Subclinical neuropathy in lead workers. Br Med J 1970; 2:80-82.
15. Seppäläinen AM, Hernberg S. Sensitive technique for detecting subclinical lead neuropathy. Br J Ind Med 1972; 29:443-449.
16. Seppäläinen AM, Tola S, Hernberg S, Kock B. Subclinical neuropathy at 'safe' levels of lead exposure. Arch Environ Health 1975; 30:180-183.